期刊文献+

雌、孕激素受体和基质金属蛋白酶-2在子宫腺肌症中的表达及意义 被引量:6

EXPRESSION AND SIGNIFICANCE OF ER,PR AND MMP-2 IN UTERINE ADENOMYOSIS
下载PDF
导出
摘要 目的探讨雌激素受体(ER)、孕激素受体(PR)及基质金属蛋白酶-2(MMP-2)在子宫腺肌病(UAM)中的表达和意义。方法应用免疫组化二步法检测35例UAM患者的异位内膜、在位内膜及38例非UAM患者正常内膜中ER、PR和MMP-2的表达情况,通过统计学方法行对照研究。结果 (1)UAM异位内膜组织中ER、PR的表达较对照正常内膜低(P<0.05);(2)UAM异位内膜中MMP-2表达水平显著高于正常内膜组(P<0.01);(3)MMP-2蛋白在UAM异位内膜中表达有周期性变化,增生期高于分泌期(P<0.05),而在在位内膜及对照内膜中表达无明显周期性变化。结论 ER表达并非子宫腺肌病的主要致病因素;MMP-2在异位内膜的高表达可能使异位内膜具有更高的侵袭性,并且在增生期表达活跃。 Objective To explore the expression and significance of ER, PR and MMP - 2 in Uterine Adenomy- osis (UAM). Methods Immunohistochemical method was employed to detect the expression of estrogen(ER) ,pro- gesterone receptor(PR) and Matrix Mealloproteinase- 2( MMP-2) in the ectopic endometrium and the eutopic en- dometrium of 35 patients with UAM and the normal controls( n = 38 ) ,then the correlation of the expression of them was analyzed. Results ( 1 ) The expression of ER and PR in ectopic endometrium were significantly lower than that in normal endometrium ( P 〈 O. 05 ) ; (2) The expression of MMP - 2 was obviously higher in the ectopic endometri- um of UAM patients than that of controls( P 〈0. O1 ) ;(3 )The expression of MMP-2 protein in ectopic endometri- um showed cyclic change obviously, the expression level of MMP -2 in proliferate stage was significantly higher than that in protestation stage (P 〈 0.05 ). But in eutopic endometrium and the normal controls showed no cyclic change. Conclusions The high expression of MMP - 2 in the ectopic endometrium suggests that the ectopic endome- trium with UAM may be more invasive and the expression was higher in proliferation stage.
出处 《青海医学院学报》 CAS 2013年第4期274-277,共4页 Journal of Qinghai Medical College
  • 相关文献

参考文献12

  • 1Ezaki K, Motoyama H, Sasaki H. Immunohistologic lo- calization of estrone sulfatase in uterine endometrium and adeno- myosis. Obstet Gynecol,2001,98 (5) :815 - 819.
  • 2李全香,郭新华.基质金属蛋白酶-2与子宫内膜异位症的相关研究[J].肿瘤防治杂志,2005,12(9):711-714. 被引量:2
  • 3Xu Q, Takekida S, Ohara N, et al. Progesterone receptor modulator CDB -2914 down- regulates proliferative cell nuclear antigen and Bcl -2 portein expression and up- regulates caspase - 3 and poly ( adeno - sine 5"- diphosphate - ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab,2005,90 (2) :953 - 961.
  • 4Sillem M, Hahn U, Coddington CC, et al. Ectopic growth of endometrium depends on its structural integrity and proteolyticactivety in the cynomolgus monkey ( Macaca fascicularis) model of endometriosis. Fertil Steril, 1996,66 ( 3 ) :468 - 473.
  • 5Sameshima T, Nabeshima k, Toole BP, etal. Expression of emmprin( CD147 ), a cell surface inducer of matrix metallo- proteinases, in normal humabrain and gliomas. Int J Cancer, 2000, 88(1) :21 -27.
  • 6Bruner KL, Matrisian LM, Rodgers WH, et al. Suppres- sion of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest, 1997,99(12) :2851 - 2857.
  • 7齐璇,辛晓燕,陈必良.MMP-2、bFGF在子宫内膜异位症和子宫腺肌病中的表达及意义[J].细胞与分子免疫学杂志,2002,18(5):474-476. 被引量:8
  • 8孙成玲.MMP-2在子宫内膜异位症中的表达及临床意义[J].细胞与分子免疫学杂志,2010,26(7):703-704. 被引量:4
  • 9Caudory S, PoletteM, Toumier JM, et al. Expression of the extracellulam atrix metalloproteinase inducer and thematrix- metalloproteinase -2 in bronchopulmonary and breast lesions. J Histochem Cytochem,2008,47 (12) : 1575 - 1580.
  • 10郎景和.子宫内膜异位症发病、诊断和治疗的“三化”理论ChinaJObstetGyneeolPediatr(ElectronEd),2012,8(4):356.

二级参考文献28

  • 1Shaco LR, Sharabi S, Benharroch D, et al. Matrix metallop-roteinas- es2and9, E-caderin and β-catenin expression in endometriosis, lowgrade endometrial carcinoma and non-neoplastic entopic endometrium [J]. Eur J Obstet Gynecol Reprod Bio.2008. 139(2):226 -232.
  • 2Kang S, Zua LF, Du H, et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China[ J]. Mol Hum Reprod, 2006, 12 ( 1 ) : 35 - 39.
  • 3Hudelist G, Lass H, Eekstein J, et al. Interleukinlalpha and tissuelyticmatrix metalloproteinase-1 are elevated in eetopie endometrium ofpatientswith endometriosis[ J ]. Hum Reprod, 2005, 20 (6) : 1695 - 1701.
  • 4Sameshima T, Nabeshima k, Toole BP, et al. Expression of emmprin ( CD147 ), a cell surface inducer of matrix metalloproteinases, in norreal humabrain and gliomas [ J]. Int J Cancer, 2000, 88 (1): 21 - 27.
  • 5Yoshida M, Sagawa N, hoh H, et al. Prostaglandin F(2alpha), cytokine and cyclic mechanical streth augment matrix metalloprotelnase-se- cretion from cultured human uterine cervical fibroblast cell[ J]. Mol Lure Reprod, 2002, 8 (7) : 681 - 687.
  • 6Caudory S, Polette M, Toumier JM, et al. Expression of the extracellulamatrix metalloproteiuase inducer and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions [ J ]. J Histochem Cytochem, 2008, 47(12) : 1575 -1580.
  • 7Sampson J. Peritomeal endometriosis is due to the menstrual dissemination of endometrial tissue into the peritoneal cavitity[J].Am J Obstet Gynecol, 1927,14(4): 422- 469.
  • 8Halme J, Hammond M G, Hulka J F, et al. Retrograde menstruation in healthy women and in patient with endometriosis[J]. Obstst Gynecol, 1984,64(2):151 154.
  • 9Sillem M, priftis, Koch A, et al. Regulation of matrix metalloproteinases and their inhibitor in uterine endometrial cells of patients with and without endomtriosis. Eur J Obstet Gynecol[J].Reprod Biol, 2001,95(2): 167- 174.
  • 10Chung H W, Wen Y, Chun S H, et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometriotic in vasiveness[J]. Fertil Steril, 2001,75(1) :152-159.

共引文献18

同被引文献110

  • 1VERIT F F, YUCEL O. Endometriosis, leiomyoma and adenomyosis : the risk of gynecologic malignancy [ J]. Asian Pacific Journal of Cancer Prevention: APJCP, 2013, 14 ( 10 ) : 5589 - 5597.
  • 2YU Jie, BOICEA A, BARRE33" K L, et al. Reduced connexin 43 in eutopic endometrium and cultured endometrial stromal cells from subjects with endometriosis [ J ]. Molecular Human Reproduction, 2014, 20 (3) : 260 -270.
  • 3Bulun SE. Endometriosis[J]. N Engl J Med, 2009, 360(3): 268-279.
  • 4Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair[J]. Arch Gynecol Obstet, 2009, 280(4):529-538.
  • 5Li XT, Qiu XY. 1713-Estradiol Upregulated Expression of ct and 13 Subunits of Larger-Conductance Calcium-Activated K (+) Channels (BK) via Estrogen Receptor 13 [J]. J Mol Neurosci, 2015, 56(4):799-807.
  • 6P6rez GJ, Torn L, Erulkar SD, et al. Characterization of large-conductance, calcium-activated potassium channels from human mynmetrium[J]. Am J Obstet Gynecol, 1993, 168 (2):652-660.
  • 7Khan RN, Smith SK, Morrison J J, et al. Ca2+ dependence and pharmacology of large-conductance K + channels in nonlabor and labor human uterine myocytes[J]. Am J Physiol, 1997, 273(5 Pt 1):C1721-C1731.
  • 8Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels[J]. Science, 1992, 256(5056):532-535.
  • 9Khan RN, Matharoo-Ball B, Arulkumaran S, et al. Potassium channels in the human myometrium[J]. Exp Physiol, 2001, 86 (2):255-264.
  • 10Wang SY, Yoshino M, Sui JL, et al. Potassium currents in freshly dissociated uterine myocytes from nonpregnant and late-pregnant rats[J]. J Gen Physiol, 1998, 112(6):737-756.

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部